| Stage | AMGN | % of rev | VIR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $10.4B | 100.00% | $239M | 100.00% | AMGN ×43.38 |
| Gross profit | $7.6B | 73.10% | $239M | 100.00% | VIR +26.9pp |
| Operating income | $3.7B | 35.79% | $73M | 30.75% | AMGN +5.0pp |
| Pre-tax income | $4.7B | 45.21% | $80M | 33.59% | AMGN +11.6pp |
| Net income | $3.9B | 37.28% | $80M | 33.51% | AMGN +3.8pp |
| Stage | AMGN | VIR | Gap · A − B |
|---|---|---|---|
| Revenue | $10.4B100.00% | $239M100.00% | AMGN ×43.38 |
| Gross profit | 73.10%$7.6B | 100.00%$239M | VIR +26.9pp |
| Operating income | 35.79%$3.7B | 30.75%$73M | AMGN +5.0pp |
| Pre-tax income | 45.21%$4.7B | 33.59%$80M | AMGN +11.6pp |
| Net income | 37.28%$3.9B | 33.51%$80M | AMGN +3.8pp |
No shared counterparties.